| Financial Year |
March 31 2023 |
| Monetary Funds |
1,458,245,211.82 |
| Held-for-trading Financial Assets |
1,218,809,534.20 |
| Notes Receivable |
-- |
| Accounts Receivable |
509,664,388.87 |
| Advances to Suppliers |
25,454,175.56 |
| Other Receivables |
106,407,422.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,282,288.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
43,952,201.38 |
| Other Current Assets |
140,078,007.53 |
| Total Current Assets |
3,538,893,230.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
321,140,374.47 |
| Long-term Equity Investment |
337,863,888.10 |
| Investment Properties |
-- |
| Fixed Assetes |
2,098,967,848.37 |
| Under-construction Projects |
82,259,372.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,478,704,444.18 |
| R&D expenses |
-- |
| Goodwill |
4,701,342,795.11 |
| Long-Term Deferred and Prepaid Expenses |
1,910,414,162.86 |
| Deferred Income Tax Assets |
1,097,834,159.83 |
| Other Non-Current Assets |
67,886,940.35 |
| Sub-Total of Non-Current Assets |
21,959,816,594.80 |
| Total Assets |
25,498,709,825.54 |
| Short-Term Loans |
999,362,097.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
118,512,554.60 |
| Accounts Received In Advance |
17,265,453.97 |
| Employee Compensation Payable |
230,164,391.60 |
| Taxes Payable |
68,359,637.40 |
| Interest Payable |
-- |
| Dividend Payable |
1,447,252.61 |
| Other payables |
1,585,880,586.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,435,095,342.28 |
| Other Current Liabilities |
417,287,113.77 |
| Sub-Total of Current Liabilities |
5,270,539,914.36 |
| Long-term Loans |
9,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
446,140,005.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
898,203,181.16 |
| Other Non-Current Liabilities |
61,119,195.38 |
| Sub-Total of Non-Current Liabilities |
9,524,273,523.68 |
| Total Liabilities |
14,794,813,438.04 |
| Paid-In Capital(Or Share Stock) |
1,118,858,874.00 |
| Capital Surplus |
7,660,146,131.59 |
| Surplus Reserve |
199,966,312.04 |
| LESS:Treasury Stock |
18,958,127.46 |
| Undistributed Profits |
1,605,565,085.46 |
| Minority Stockholder's Interest |
139,309,175.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,564,587,212.20 |
| Owner's Equity（Stockholder's Equity） |
10,703,896,387.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,498,709,825.54 |
